We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 529.00
Bid: 529.00
Ask: 533.00
Change: -3.00 (-0.56%)
Spread: 4.00 (0.756%)
Open: 525.00
High: 535.00
Low: 525.00
Prev. Close: 532.00
POLR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AUM Update

11 Apr 2019 07:00

RNS Number : 8235V
Polar Capital Holdings PLC
11 April 2019
 

 

11 April 2019 Polar Capital Holdings plc

AUM Update

 

 

Polar Capital Holdings plc ("Polar Capital" or the "Group"), the specialist asset management group, today provides its regular quarterly update of its unaudited statement of its assets under management ("AUM") for the financial year to 31 March 2019.

 

Group AUM (unaudited)

 

Polar Capital reports that as at 31 March 2019 its AUM were £13.8bn compared to £12.0bn at the end of March 2018, an increase of 15% over the year.

 

AUM movement in twelve months to 31 March 2019

Long-only

funds

Alternative funds

Total

AUM at

1 April 2018

£10,812m

£1,168m

£11,980m

Net subscriptions

£427m

£129m

£556m

Market movement

and performance

£1,290m

£9m

£1,299m

Total AUM at

31 March 2019

£12,529m

£1,306m

£13,835m

 

 

 

Comment

 

While the Group reports AUM at a record year-end high of £13.8bn, an increase of £1.8bn over the financial year, over the past twelve months we have experienced material fluctuations in the Group's AUM. Before the market sell-off in October, AUM reached an all time high of £14.7bn at the end of the first half in September but following the market correction in the final calendar quarter AUM declined to £12.7bn as at 31 December 2018. The strong market recovery in the recent quarter lifted AUM by £1.1bn to £13.8bn.

 

During the financial year, net inflows amounted to £556m as a result of positive net inflows in the first half of £932m followed by net outflows of £286m in the December quarter and a significantly reduced rate of net outflows of £90m in the recent quarter to 31 March 2019. Net flows in April have to date been positive.

 

Despite the market volatility over the second half, the Group's funds have performed well resulting in a record year for net performance fee profits of £23.6m which crystallised on 31 December 2018.

 

Gavin Rochussen, Chief Executive, commented:

 

"Polar Capital has had a year of two halves with strong growth in AUM through net inflows, performance and markets in the first half followed by reduced risk appetite for our specialist fund strategies following the global sell-off and market correction in October and December of 2018. Net flows have stabilised and funds have continued to perform in line with our expectation, with 76% of the Group's AUM ahead of their benchmarks annualised over three years to 31 March 2019. In the last quarter, the majority of AUM and fund strategies outperformed their respective benchmarks."

 

"With a diverse range of actively managed specialist fund strategies, Polar Capital is positioned to continue performing for its clients and has capacity to attract additional net inflows. Market volatility is expected to remain as political tensions continue and as Brexit, with an unpredictable outcome, runs its course."

 

Polar Capital will announce its results for the financial year to 31 March 2019 on 24 June 2019.

 

For further information please contact:

 

Polar Capital

Gavin Rochussen (Chief Executive)John Mansell (COO)

+44 (0)20 7227 2700

Numis Securities Limited - Nomad and Joint Broker

Charles Farquhar

Stephen Westgate

Kevin Cruickshank (QE)

+44 (0)20 7260 1000

 

 

Peel Hunt LLP - Joint Broker

Guy Wiehahn

 

+44 (0)20 7418 8893

 

Camarco

Ed Gascoigne-Pees

 

 

+44 (0)20 3757 4984

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCEAKLEFFKNEFF
Date   Source Headline
17th Apr 20243:55 pmRNSDirector/PDMR Shareholding
12th Apr 20245:43 pmRNSHolding(s) in Company
11th Apr 20247:00 amRNSAuM Update
9th Apr 20244:01 pmRNSChange of Company Secretary
15th Mar 20243:02 pmRNSForm 8.3 - Renalytix PLC
15th Mar 202410:23 amRNSForm 8.3 - Renalytix PLC - Replacement
13th Mar 20246:14 pmRNSForm 8.3 - RENALYTIX PLC
7th Mar 20244:30 pmRNSHolding(s) in Company
6th Mar 20245:47 pmRNSForm 8.3 - DIRECT LINE INSURANCE GROUP PLC
6th Mar 20245:37 pmRNSForm 8.3 - RENALYTIX PLC
27th Feb 20242:19 pmRNSForm 8.3 - Wincanton PLC
7th Feb 20242:09 pmRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSBlock listing Interim Review
25th Jan 20244:53 pmRNSForm 8.3 -Wincanton PLC
11th Jan 20247:00 amRNSAuM Update
10th Jan 20242:54 pmRNSHolding(s) in Company
10th Jan 20242:51 pmRNSHolding(s) in Company
20th Nov 20237:00 amRNSPolar Capital Holdings Unaudited interim results
9th Nov 20237:00 amRNSInvestor Presentation covering Interim Results
26th Oct 20237:00 amRNSNotice of Interim Results
12th Oct 20237:00 amRNSAuM Update
28th Sep 20235:36 pmRNSResult of AGM
18th Aug 20234:45 pmRNSDirector/PDMR Shareholding
1st Aug 202312:05 pmRNSBlock listing Interim Review
19th Jul 20234:34 pmRNSDirector/PDMR Shareholding
18th Jul 20234:30 pmRNSDirector/PDMR Shareholding
13th Jul 202311:01 amRNSDirector/PDMR Shareholding - Replacement
13th Jul 202310:48 amRNSDirector/PDMR Shareholding
13th Jul 202310:31 amRNSDirector/PDMR Shareholding
13th Jul 20237:00 amRNSAuM Update
26th Jun 20233:34 pmRNSInvestor Presentation covering Full Year Results
26th Jun 20237:00 amRNSGroup Audited Results for year ended 31 March 2023
1st Jun 20237:00 amRNSTotal Voting Rights
25th May 202312:26 pmRNSIssue of Equity
10th May 20233:10 pmRNSDirector/PDMR Shareholding
21st Apr 20232:36 pmRNSHolding(s) in Company
14th Apr 20234:01 pmRNSDirector/PDMR Shareholding
13th Apr 20237:00 amRNSAuM Update
31st Mar 202312:23 pmRNSDirector/PDMR Shareholding
10th Mar 20233:17 pmRNSDirector/PDMR Shareholding
24th Feb 20235:18 pmRNSForm 8.3 - REDX Pharma PLC
16th Feb 20235:06 pmRNSDirector/PDMR Shareholding
7th Feb 202311:09 amRNSHolding(s) in Company
1st Feb 20237:00 amRNSBlock listing Interim Review
12th Jan 20237:00 amRNSAuM Update
30th Dec 20227:00 amRNSDirectorate Change
21st Nov 20227:00 amRNSUnaudited interim results
15th Nov 20227:00 amRNSInvestor Presentation covering Interim Results
24th Oct 20227:00 amRNSNotice of Results
19th Oct 20222:52 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.